Qiagen to Focus Nascent NGS Business on Sample Prep and Clinical Market | GenomeWeb

This article has been updated from a version posted Nov. 6 to include additional comments from Qiagen.

Qiagen this week launched four new next-gen sequencing related products, all of which will focus on sample prep, and one of which will be geared specifically toward the clinical sequencing market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.